Back to UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

IONSIONS
Showing 8 of 30 quarters

Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in IONIS PHARMACEUTICALS INC

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 1.5M shares of IONS (IONIS PHARMACEUTICALS INC), worth $110.8M as of 2026-Q1. The position was increased (+6.3% shares). IONS represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.

Current Value

$110.8M

Current Shares

1.5M

Total Value Change

+$95.5M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.5M
+6.3%
$110.8M0.0%$78.66
32
2025-Q4
Increased
1.4M
+20.3%
$109.8M0.0%$78.97
36
2025-Q3
Increased
1.2M
+45.9%
$75.5M0.0%$64.15
40
2025-Q2
Increased
791,072
+20.0%
$31.3M0.0%$39.80
34
2025-Q1
Increased
659,435
+6.4%
$19.9M0.0%$31.15
30
2024-Q4
Increased
619,641
+116.9%
$21.7M0.0%$34.92
46
2024-Q3
Decreased
285,697
-10.8%
$11.4M0.0%$40.85
0
2024-Q2
Increased
320,290
+71.9%
$15.3M0.0%$47.66
42

Other major holders of IONS: FMR LLC, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used